PANCREATIC TUMOR CELL VACCINE (GVAX), LOW DOSE CYCLOPHOSPHAMIDE, FRACTIONATED STEREOTACTIC BODY RADIATION THERAPY (SBRT), AND FOLFIRINOX CHEMOTHERAPY IN PATIENTS WITH RESECTED ADENOCARCINOMA OF THE PANCREAS: